İçeriğe geç
akaturk Akademik ölçüm

Akademisyen

EBRU DİDEM KURAN

DOKTOR ÖĞRETİM ÜYESİ

FENERBAHÇE ÜNİVERSİTESİ ECZACILIK FAKÜLTESİ ECZACILIK MESLEK BİLİMLERİ BÖLÜMÜ

  • Ana Dal Sağlık Bilimleri Temel Alanı
  • Yan Dal Farmasotik Kimya

Kayıtlı çıktılara kısa bakış — ayrıntılar aşağıda.

  • Makale 21
  • Proje 0
  • Kitap 0
  • Bildiri 4
  • Patent 0
  • Sanatsal 0
Scopus (SJR) Q1 0 Q2 10 Q3 7 Q4 2
WoS (JCR) Q1 0 Q2 9 Q3 7 Q4 5
TR Index 2 makale

Alan+yıl+tür normalize OpenAlex yüzdelik — Clarivate ESI / SciVal değildir.

Üst %1 makale 0
Üst %10 makale 8
Ort. yüzdelik 71.5%
Üst %1 payı 0.0%
Üst %10 payı 38.1%

Makaleler

YÖKSİS ve OpenAlex kaynak ayrımıyla makaleler; quartile ve TR Index ile daraltabilirsiniz.

Dizin filtreleri

Toplam 21 yayın

Scopus (SJR)
WoS (JCR)
TR Index

Makale listesi

  1. 2026 Synthesis, Experimental and Quantum Mechanical Investigation of the Crystal Structures of Two Triazolyl-Indole Compounds, Along with the Evaluation of Their Antioxidant Activity Journal of Molecular Structure DOI 10.1016/j.molstruc.2026.145711 YÖKSİS SJR Q2 JCR Q2 OpenAlex 10.6%
  2. 2026 Sub-Cytotoxic Mitochondrial Stress in Cardiomyocytes and Whole-Organism Toxicity in C. elegans Induced by Molnupiravir International Journal of Toxicology DOI 10.1177/10915818261440558 YÖKSİS SJR Q3 JCR Q4 OpenAlex 29.5%
  3. 2025 Molecular docking approach to identify Bcl-xL inhibitory effect of sesquiterpene coumarins of Ferula species İstanbul Journal of Pharmacy DOI 10.26650/IstanbulJPharm.2025.1070319 YÖKSİS TR Index JCR Q4 OpenAlex 1.6%
  4. 2025 Synthesis, Characterization, and Antimicrobial Evaluation of Some Novel Hydrazinecarbothioamides Turkish Journal of Pharmaceutical Sciences DOI 10.4274/tjps.galenos.2025.90304 YÖKSİS TR Index SJR Q2 JCR Q4 OpenAlex 81.1%
  5. 2025 Discovery of Dual‐Inhibitor Acyl Hydrazones for Acetylcholinesterase and Carbonic Anhydrase I/II: A Mechanistic Insight into Alzheimers Disease ChemistrySelect DOI 10.1002/slct.202405876 YÖKSİS SJR Q3 JCR Q3 OpenAlex üst %10 OpenAlex 92.5%
  6. 2025 Preliminary Investigations on Acyl Hydrazones Bearing Sulfonamides as Inhibitors of the Human Carbonic Anhydrase Isoforms I, II, IX, and XII Anti-Cancer Agents in Medicinal Chemistry DOI 10.2174/0118715206356980250113074705 YÖKSİS SJR Q3 JCR Q3 OpenAlex 53.6%
  7. 2025 Novel 4-((3-fluorobenzyl)oxy)benzohydrazide derivatives as promising anti-prostate cancer agents: Synthesis, characterization and in vitro & in silico biological activity studies Journal of Molecular Structure DOI 10.1016/j.molstruc.2024.140702 YÖKSİS SJR Q2 JCR Q2 OpenAlex üst %10 OpenAlex 98.2%
  8. 2024 Synthesis and in vitro carbonic anhydrase and acetylcholinesterase inhibitory activities of novel hydrazide–hydrazone compounds containing 1,2,4-triazole ring Phosphorus, Sulfur, and Silicon and the Related Elements DOI 10.1080/10426507.2024.2320672 YÖKSİS SJR Q4 JCR Q3 OpenAlex 85.5%
  9. 2024 Design, synthesis, and evaluation of novel bistrifluoromethyl‐based hydrazones as dual inhibitors of acetylcholinesterase and carbonic anhydrase enzymes for Alzheimers disease Chemical Biology & Drug Design DOI 10.1111/cbdd.14482 YÖKSİS SJR Q2 JCR Q2 OpenAlex 83.6%
  10. 2023 Emodin and aloe-emodin, two potential molecules in regulating cell migration of skin cells through the MAP kinase pathway and affecting Caenorhabditis elegans thermotolerance BMC MOLECULAR AND CELL BIOLOGY DOI 10.1186/s12860-023-00486-1 YÖKSİS SJR Q3 JCR Q4 OpenAlex üst %10 OpenAlex 91.8%
  11. 2023 A newly synthesized thiosemicarbazide derivative trigger apoptosis rather than necroptosis on HEPG2 cell line Chemical Biology & Drug Design DOI 10.1111/cbdd.14355 YÖKSİS SJR Q2 JCR Q2 OpenAlex 55.4%
  12. 2023 Design, synthesis and biological evaluation of novel tetralone/indanone containing thiosemicarbazone derivatives with selective COX-2 inhibition as anticancer agents Journal of Molecular Structure DOI 10.1016/j.molstruc.2023.135626 YÖKSİS SJR Q2 JCR Q2 OpenAlex 61.9%
  13. 2025 Discovery of Dual-Inhibitor Acyl Hydrazones for Acetylcholinesterase and Carbonic Anhydrase I/II: A Mechanistic Insight into Alzheimer's Disease ChemistrySelect DOI 10.1002/slct.202405876 YÖKSİS SJR Q3 JCR Q3 OpenAlex üst %10 OpenAlex 92.3%
  14. 2025 Novel 4-((3-fluorobenzyl)oxy)benzohydrazide derivatives as promising anti-prostate cancer agents: Synthesis, characterization and in vitro & in silico biological activity studies Journal of Molecular Structure DOI 10.1016/j.molstruc.2024.140702 YÖKSİS JCR Q2 OpenAlex üst %10 OpenAlex 98.2%
  15. 2025 Preliminary Investigations on Acyl Hydrazones Bearing Sulfonamides as Inhibitors of the Human Carbonic Anhydrase Isoforms I, II, IX, and XII. Anticancer Agents in Medicinal Chemistry DOI 10.2174/0118715206356980250113074705 YÖKSİS SJR Q3 JCR Q3 OpenAlex 53.6%
  16. 2024 Design, synthesis, and evaluation of novel bistrifluoromethyl-based hydrazones as dual inhibitors of acetylcholinesterase and carbonic anhydrase enzymes for Alzheimer's disease CHEMICAL BIOLOGY & DRUG DESIGN DOI 10.1111/cbdd.14482 YÖKSİS SJR Q2 JCR Q2 OpenAlex 83.6%
  17. 2024 Synthesis and in vitro carbonic anhydrase and acetylcholinesterase inhibitory activities of novel hydrazide-hydrazone compounds containing 1,2,4-triazole ring PHOSPHORUS SULFUR AND SILICON AND THE RELATED ELEMENTS DOI 10.1080/10426507.2024.2320672 YÖKSİS SJR Q4 JCR Q3 OpenAlex 85.4%
  18. 2023 Design, synthesis and biological evaluation of novel tetralone/indanone containing thiosemicarbazone derivatives with selective COX-2 inhibition as anticancer agents Journal of Molecular Structure DOI 10.1016/j.molstruc.2023.135626 YÖKSİS SJR Q2 JCR Q2 OpenAlex 61.9%
  19. 2023 Emodin and aloe-emodin, two potential molecules in regulating cell migration of skin cells through the MAP kinase pathway and affecting Caenorhabditis elegans thermotolerance BMC Molecular and Cell Biology DOI 10.1186/s12860-023-00486-1 YÖKSİS SJR Q3 JCR Q4 OpenAlex üst %10 OpenAlex 91.8%
  20. 2022 Design, synthesis, characterization, molecular docking studies and anticancer activity evaluation of novel hydrazinecarbothioamide, 1,2,4-triazole-3-thione, 4-thiazolidinone and 1,3,4-oxadiazole derivatives JOURNAL OF MOLECULAR STRUCTURE DOI 10.1016/j.molstruc.2022.133710 YÖKSİS SJR Q2 JCR Q2 OpenAlex üst %10 OpenAlex 93.5%

Akademisyenlere dön